Zhejiang NHU Company Ltd.
Q3 2022 Report
The Company and whole members of the BOD guarantee that the information disclosed is authentic,accurate, complete and free from any false records, misleading statements or significant omissions.
Important Content Reminder:
1. The Board of Directors, Board of Supervisors, directors, supervisors and senior executives ofZhejiang NHU Company Ltd. (hereinafter referred to as the “Company”) hereby guarantee that theinformation presented in this report is authentic, accurate, complete and free of any false records,misleading statements or material omissions, and they will bear joint and several liabilities for suchinformation.
2. The Company’s legal representative, the person in charge of finance and accounting work, and theperson in charge of accounting institution (Accounting Officer) hereby declare and warrant that thefinancial statements in this report are authentic, accurate and complete.
3. Whether the Third Quarterly Report has been audited or not
□ Yes √ No
Note:
This Report has been prepared in both Chinese and English version, and the English version is forreference only. Should there be any discrepancies or misunderstandings between the two versions,the Chinese versions shall prevail. The complete published Chinese Third Quarterly Report may beobtained at www.cninfo.com.cn.
Section Ⅰ Key Accounting DataⅠ Key Accounting Data and Financial IndicatorsWhether the Company needs performed retroactive adjustment or restatement of accounting data in prior years or not
√ Yes □ No
Retroactive adjustment or restatement of reasonsAccounting policy changes and other reasons
Items | Q3 2022 | Q3 2021 | YoY Change(%) | Q1-Q3 2022 | Q1-Q3 2021 | YoY Change(%) | ||
Before Adjustment | After Adjustment [Note2] | After Adjustment | Before Adjustment | After Adjustment [Note2] | After Adjustment | |||
Operating revenue (yuan) | 3,694,978,856.40 | 3,262,074,936.89 | 3,273,918,382.43 | 12.86% | 11,910,018,133.43 | 10,516,296,574.90 | 10,614,042,692.54 | 12.21% |
Net profit attributable to shareholders of listed company (yuan) | 797,168,419.00 | 957,591,164.57 | 965,016,497.48 | -17.39% | 3,011,045,838.25 | 3,366,090,298.07 | 3,391,995,645.90 | -11.23% |
Net profit attributable to shareholders of listed company after deducting non-recurring profit or loss (yuan) | 833,476,722.26 | 922,007,774.31 | 929,479,753.83 | -10.33% | 2,927,532,671.88 | 3,201,462,429.94 | 3,227,398,347.79 | -9.29% |
Net cash flows from operating activities (yuan) | - | - | - | - | 2,527,486,364.07 | 3,830,824,490.52 | 3,856,729,838.35 | -34.47% |
Basic EPS (yuan/share) | 0.26 | 0.37[Note1] | 0.31 | -16.13% | 0.98 | 1.31[Note1] | 1.10 | -10.91% |
Diluted EPS (yuan/share) | 0.26 | 0.37[Note1] | 0.31 | -16.13% | 0.98 | 1.31[Note1] | 1.10 | -10.91% |
Weighted average ROE | 2.95% | 4.53% | 4.79% | Decrease 1.84 percentage points | 12.50% | 16.55% | 16.66% | Decrease 4.16 percentage points |
Items | September 30, 2022 | December 31, 2021 | Change(%) | |||||
Before Adjustment | After Adjustment | After Adjustment | ||||||
Total assets (yuan) | 38,245,908,900.33 | 34,692,165,111.88 | 34,724,025,476.79 | 10.14% | ||||
Net assets attributable to shareholders of listed company (yuan) | 22,982,303,553.60 | 21,799,977,645.94 | 21,831,838,010.85 | 5.27% |
[Note1] After the implementation of the Company’s 2021 profit distribution plan, its share capital was increased from 2,578,394,760shares to 3,090,907,356 shares. The above EPS of the comparative period was recalculated based on the adjusted share capital.[Note2] The company has implemented The Interpretation of Accounting Standards for Business Enterprises No. 15 since January 1,2022. The interpretation requires that if the company sells the products or by-products produced before the fixed assets reach theexpected serviceable state or during the research and development process, the income and cost related to the trial operation sales shallbe accounted for separately and included in the current profit and loss, The net amount of the revenue from trial operation sales afteroffsetting the relevant costs shall not be used to offset the cost of fixed assets or R&D expenses. The company makes retroactiveadjustment according to requirements.
II Non-recurring gains and losses for this period
√ Applicable □ Not applicable
Unit: RMB
Item | Q3 2022 | Q1-Q3 2022 |
Gains or losses on disposal of non-current assets, including write-off of provision for impairment | -5,447,443.35 | 1,227,407.46 |
Government grants included in profit or loss (excluding those closely related to operating activities of the Company, satisfying government policies and regulations, and continuously enjoyed with certain quantity or quota based on certain standards) | 43,647,316.95 | 129,169,496.49 |
Gains or losses on assets consigned to the third party for investment or management | 6,301,416.49 | 35,143,068.10 |
Gains or losses on changes in fair value of held-for-trading financial assets and held-for-trading financial liabilities, and investment income from disposal of held-for-trading financial assets and held-for-trading financial liabilities, excluding those arising from hedging business related to operating activities | -80,247,557.93 | -71,175,659.01 |
Other non-operating revenue or expenditures | 2,266,524.91 | 3,064,330.15 |
Less: Enterprise income tax affected | 2,810,884.07 | 13,857,733.23 |
Non-controlling interest affected (after tax) | 17,676.26 | 57,743.59 |
Total | -36,308,303.26 | 83,513,166.37 |
Remarks on other profit or loss satisfying the definition of non-recurring profit or loss:
□ Applicable √ Not Applicable
The Company has no other profit or loss satisfying the definition of non-recurring profit or loss.Remarks on defining non-recurring profit or loss listed in the “Interpretation Pronouncement on Information Disclosure Criteria forPublic Companies No. 1 – Non-Recurring Profit or Loss” as recurring profit or loss.
□ Applicable √ Not Applicable
The Company has no situation of defining non-recurring profit or loss listed in the “Interpretation Pronouncement on InformationDisclosure Criteria for Public Companies No. 1 – Non-Recurring Profit or Loss” as recurring profit or lossIII Major Changes of Main Items in Financial Statements and Financial Indicators within the ReportingPeriod, as well as the Reasons for the Changes
√ Applicable □Not applicable
1.Balance Sheet Position
(1) The closing balance of held-for-trading financial assets decreased by 68.02% compared to the opening balance in this year. It wasmainly due to the maturity of idle funds raised during the reporting period of financial products.
(2) The closing balance of receivables financing increased by 77.00% compared to the opening balance in this year. It was mainly dueto the increase in bank acceptance bills received during the reporting period
(3) The closing balance of advances paid increased by 162.64% compared to the opening balance in this year. It was mainly due to theincrease in raw material purchases during the reporting period
(4) The closing balance of other current assets decreased by 92.66% compared to the opening balance in this year. It was mainly dueto the the maturity redemption of financial products of idle funds raised during the reporting period.
(5) The closing balance of other non-current assets increased by 51.74% compared to the opening balance in this year. It was mainlydue to the increase of prepayment in equipment during the reporting period.
(6) The closing balance of short-term borrowings increased by 66.47% compared to the opening balance in this year. It was mainly dueto the increase in bank borrowings for operating business during the reporting period
(7) The closing balance of other payables increased by 134.98% compared to the opening balance in this year. It was mainly due to thesubsidiary owed shareholders during the reporting period.
(8) The closing balance of deferred tax liabilities increased by 41.59% compared to the opening balance in this year. It was mainlycaused by the one-time deduction of the taxable income amount from the newly added fixed assets and the calculation and withdrawalof deferred income tax liabilities during the reporting period.
(9) The closing balance of treasury shares increased by 56.09% compared to the opening balance in this year. It was mainly due to therepurchase of part of companies’ social public shares.
(10) The closing balance of other comprehensive incomes increased by 5,815.88% compared to the opening balance in this year. It wasmainly due to the difference of translating foreign currency financial statement.
2. Income Statement Position
(1) Operating cost in the current Q1-Q3 period increased by 30.57% compared to the same period of last year. It was mainly due to theincrease in the price of raw materials and product sales resulting in higher costs in the current Q1-Q3 period.
(2) Financial expenses in the current Q1-Q3 period decreased by 87.64% compared to the same period of last year. It was mainly dueto exchange gains arising from exchange rate fluctuations in the current Q1-Q3 period.
(3) Investment income in the current Q1-Q3 period increased by 34.11% compared to the same period of last year. It was mainly dueto the increase in income from investment in associates in the current Q1-Q3 period.
(4) Gains on changes in fair value in the current Q1-Q3 period decreased by 258.11% compared to the same period of last year. It wasmainly due to the change in the value of forward foreign settlement and sales products caused by the change in exchange rate in thecurrent Q1-Q3 period.
(5) Credit impairment loss in the current Q1-Q3 period decreased by 224.91% compared to the same period of last year. It was mainlydue to the increase in receivables collection resulting in the reduction of bad debts in the current Q1-Q3 period.
(6) Gains on asset disposal in the current Q1-Q3 period increased by 335.16% compared to the same period of last year. It was mainlydue to the gains on disposal of non-current assets in the current Q1-Q3 period.
(7) Non-operating revenues in the current Q1-Q3 period decreased by 57.41% compared to the same period of last year. It was mainlydue to changes in compensation received in the current Q1-Q3 period.
3. Cash Flow Statement Position
(1) Net cash flows from operating activities in the current Q1-Q3 period decreased by 34.47% compared to the same period of last year.It was mainly due to the increase of raw material purchase during the reporting period in the current Q1-Q3 period.
(2) Net cash flows from financing activities in the current Q1-Q3 period increased by 200.46% compared to the same period of lastyear. It was mainly due to the the reduction of cash expenditure for repayment of borrowings in the current Q1-Q3 period.
Section Ⅰ Shareholders InformationⅠ Total Number of Common Shareholders and Number of Preferred Shareholders with Voting RightsRecovered and Information about Top 10 Shareholders
Unit: share
Total number of common shareholders at the end of the reporting period | 89,376 | Total number of preferred shareholders whose voting rights have been recovered at the end of the reporting period | 0 | |||
Information about top 10 shareholders | ||||||
Shareholders | Nature of shareholders | Holding proportion | Quantity of shares | Quantity of restricted shares | Shares pledged, marked or frozen | |
Condition | Quantity | |||||
NHU Holding Group Co., Ltd. | Domestic non-state-owned legal person | 49.07% | 1,516,802,525 | 0 | ||
Hong Kong Securities Clearing Company Limited | Overseas legal person | 2.32% | 71,757,705 | 0 | ||
Shanghai Chongyang Strategic Investment Co., Ltd. - Chongyang Strategic Huizhi Fund | Others | 1.75% | 54,072,200 | 0 | ||
National Social Security Fund No.503 Portfolio | Others | 1.04% | 32,000,000 | 0 | ||
Shanghai Chongyang Strategic Investment Co., Ltd. - Chongyang Strategic Yingzhi Fund | Others | 0.53% | 16,248,559 | 0 | ||
China Construction Bank Co., Ltd.- E Fund CSI 300 Medicine Health Trading Open Index Securities Investment Fund | Others | 0.48% | 14,701,859 | 0 | ||
Hu Baishan | Domestic natural person | 0.47% | 14,595,929 | 10,946,946 | ||
Chongyang Group Co., Ltd. | Domestic non-state-owned legal person | 0.45% | 13,962,191 | 0 | ||
Hu Baifan | Domestic natural person | 0.45% | 13,922,998 | 10,442,248 | ||
Sanhua Holding Group Co., Ltd. | Domestic non-state-owned legal person | 0.45% | 13,772,970 | 0 | ||
Information about top 10 shareholders without trading restrictions | ||||||
Shareholders | Quantity of non-restricted shares | Category of shares | ||||
Category | Quantity | |||||
NHU Holding Group Co., Ltd. | 1,516,802,525 | RMB ordinary shares | 1,516,802,525 | |||
Hong Kong Securities Clearing Company Limited | 71,757,705 | RMB ordinary shares | 71,757,705 | |||
Shanghai Chongyang Strategic Investment Co., Ltd. - Chongyang Strategic Huizhi Fund | 54,072,200 | RMB ordinary shares | 54,072,200 | |||
National Social Security Fund No.503 Portfolio | 32,000,000 | RMB ordinary shares | 32,000,000 |
Shanghai Chongyang Strategic Investment Co., Ltd. - Chongyang Strategic Yingzhi Fund | 16,248,559 | RMB ordinary shares | 16,248,559 |
China Construction Bank Co., Ltd.- E Fund CSI 300 Medicine Health Trading Open Index Securities Investment Fund | 14,701,859 | RMB ordinary shares | 14,701,859 |
Chongyang Group Co., Ltd. | 13,962,191 | RMB ordinary shares | 13,962,191 |
Sanhua Holding Group Co., Ltd. | 13,772,970 | RMB ordinary shares | 13,772,970 |
Kuwait Investment Authority | 13,759,402 | RMB ordinary shares | 13,759,402 |
Agricultural Bank of China Co., Ltd. - Franklin Guohai Deepening Value Hybrid Securities Investment Fund | 13,187,519 | RMB ordinary shares | 13,187,519 |
Explanation on associated relationship or concerted actions among above shareholders | Among the above shareholders, Hu Baifan is the chairman of the board, general manager and actural controller of NHU Holding Group Co., Ltd.; Hu Baishan is the director of NHU Holding Group Co., Ltd., and Hu Baifan and Hu Baishan are brothers. The Company does not know whether other shareholders have relationships and whether they are persons acting in concert as defined in Administration of the Takeover of Listed Companies Procedures. | ||
Explanation on top 10 shareholders’ participating in securities margin trading | Shanghai Chongyang Strategic Investment Co., Ltd. - Chongyang Strategic Huizhi Fund holds 54,072,127 shares through client account of collateral securities for margin trading of Guotai Junan Securities Co., Ltd.; Shanghai Chongyang Strategic Investment Co., Ltd. - Chongyang Strategic Yingzhi Fund holds 16,248,461 shares through client account of collateral securities for margin trading of Citic Securities Co., Ltd.; Chongyang Group Co., Ltd. holds 13,961,946 shares through client account of collateral securities for margin trading of China Merchants Securities Co., Ltd.. |
Notes: Zhejiang NHU Co., Ltd. Repurchase Securities Account is among top 10 shareholders at the end of the reporting period, but donot participate in the listing of the top 10 shareholders of the company.II Total Number of Preferred Shareholders and Information about Top 10 Preferred Shareholders
□ Applicable √Not applicable
Section III Other Significant Events
√Applicable □Not applicable
I Progress of shareholding increase by controlling shareholdersBased on the confidence in the sustainable and stable development of the company in the future and the recognition of the company'svalue, and to enhance investors’ confidence, the controlling shareholder of the company, NHU Holding Group Co., Ltd plans to increaseits holdings of the company's shares in the next six months through the ways allowed by the trading system of Shenzhen Stock Exchange(including but not limited to centralized bidding, block trading, etc.), and the amount of shares to be increased is not less than RMB300 mn and not more than RMB 600 mn. There is no price range in this shareholding increase plan, and the shareholding increase planwill be gradually implemented according to the fluctuation of the company's stock price and the overall trend of the capital market. Formore details, please refer to The Announcement of Controlling Shareholders’ Share Increase Plan (2022-031) published on thecompany's designated information disclosure media and cninfo( http://www.cninfo.com.cn )on May 18, 2022. By September 30,2022, NHU Holding Group Co., Ltd had increased its holdings by 14,518,152 shares.
II Progress of Investment Project with Raised FundsWith the approval of [2017] No. 1684 document of China Securities Regulatory Commission, the company's lead underwriter, CSCSecurities Co., Ltd., privately issued 175 million common shares (A shares) to specific objects at an issue price of RMB 28.00/share,raising a total of RMB 4,900 million. After deducting the underwriting and recommendation fees of RMB 30 million yuan (includingtax), the raised funds amounted to RMB 4,870 million, which was remitted to the raised funds supervision account of the company bythe lead underwriter, CSC Securities Co., Ltd. on December 7, 2017. In addition, after deducting lawyer fees, audit fees, capitalverification fees and other issuance expenses of RMB 4.62 million (excluding tax), and considering the deductible VAT input tax ofRMB 1.70 million of underwriting fees and recommendation fees deducted by the lead underwriter, the net amount of funds raised wasRMB 4,867.08 million. The availability of the above raised funds has been verified by Tianjian Certified Public Accountants (specialgeneral partnership), who issued the capital verification report ([2017] No. 503).From January 1 to September 30, 2022, the actual use of the raised funds was RMB 1,187.00 mn, and the accumulated investment ofthe raised funds project was RMB 3,274.45 mn. By September 30, 2022, the balance of raised funds was RMB 2,294.79 mn (includingfinancial products and structured deposits, the net amount of interest on cash in bank less handling charges, gains on financial productsand structured deposits received on an accumulated basis).
Section Ⅳ Quarterly Financial StatementsⅠ Financial statements
1. Consolidated balance sheet
Prepared by Zhejiang NHU Co., Ltd.
September 30, 2022
Unit: RMB Yuan
Items | September 30, 2022 | January 1, 2022 |
Current assets: | ||
Cash and bank balances | 7,141,557,642.42 | 5,952,909,626.94 |
Settlement funds | ||
Loans to other banks | ||
Held-for-trading financial assets | 400,000,000.00 | 1,250,736,359.24 |
Derivative financial assets | ||
Notes receivable | 364,261,478.14 | 349,145,316.03 |
Accounts receivable | 2,390,691,753.18 | 2,755,168,573.14 |
Receivables financing | 323,714,583.61 | 182,891,179.65 |
Advances paid | 207,408,794.52 | 78,969,960.60 |
Premiums receivable | ||
Reinsurance accounts receivable | ||
Reinsurance reserve receivable | ||
Other receivables | 257,240,401.67 | 254,497,248.13 |
Including: Interest receivable | ||
Dividend receivable | ||
Financial assets under reverse repo | ||
Inventories | 4,123,609,039.61 | 3,193,657,367.16 |
Contract assets | ||
Assets held for sale | ||
Non-current assets due within one year | ||
Other current assets | 65,767,719.02 | 895,782,268.87 |
Total current assets | 15,274,251,412.17 | 14,913,757,899.76 |
Non-current assets: | ||
Loans and advances | ||
Debt investments |
Items | September 30, 2022 | January 1, 2022 |
Other debt investments | ||
Long-term receivables | ||
Long-term equity investments | 420,345,116.37 | 351,327,625.75 |
Other equity instrument investments | 22,998,147.55 | 22,998,147.55 |
Other non-current financial assets | ||
Investment property | ||
Fixed assets | 16,490,499,124.60 | 14,350,779,852.73 |
Construction in progress | 3,456,613,151.06 | 2,984,835,072.82 |
Productive biological assets | ||
Oil & gas assets | ||
Right-of-use assets | 2,947,987.05 | 3,123,637.11 |
Intangible assets | 1,743,112,711.59 | 1,521,729,757.66 |
Development expenditures | ||
Goodwill | 4,410,005.33 | |
Long-term prepayments | 14,835,697.22 | 18,591,707.06 |
Deferred tax assets | 55,555,626.65 | 55,805,191.95 |
Other non-current assets | 760,339,920.74 | 501,076,584.40 |
Total non-current assets | 22,971,657,488.16 | 19,810,267,577.03 |
Total assets | 38,245,908,900.33 | 34,724,025,476.79 |
Current liabilities: | ||
Short-term borrowings | 2,336,172,712.77 | 1,403,332,827.92 |
Central bank loans | ||
Loans from other banks | ||
Held-for-trading financial liabilities | 58,195,058.11 | |
Derivative financial liabilities | ||
Notes payable | 869,349,399.24 | 694,124,946.73 |
Accounts payable | 1,581,290,501.98 | 1,435,966,427.76 |
Advances received | ||
Contract liabilities | 75,487,524.38 | 61,135,258.36 |
Financial liabilities under repo | ||
Absorbing deposit and interbank deposit | ||
Deposit for agency security transaction | ||
Deposit for agency security underwriting |
Items | September 30, 2022 | January 1, 2022 |
Employee benefits payable | 288,562,337.36 | 370,609,333.07 |
Taxes and rates payable | 294,653,594.26 | 420,743,262.69 |
Other payables | 133,260,314.27 | 56,712,103.36 |
Including: Interest payable | ||
Dividend payable | ||
Handling fee and commission payable | ||
Reinsurance accounts payable | ||
Liabilities held for sale | ||
Non-current liabilities due within one year | 2,538,748,536.10 | 2,029,499,509.43 |
Other current liabilities | 6,534,145.98 | 5,133,310.10 |
Total current liabilities | 8,182,254,124.45 | 6,477,256,979.42 |
Non-current liabilities: | ||
Insurance policy reserve | ||
Long-term borrowings | 5,750,146,727.09 | 5,148,811,786.49 |
Bonds payable | ||
Including: Preferred shares | ||
Perpetual bonds | ||
Lease liabilities | 2,841,901.64 | 2,936,868.15 |
Long-term payables | ||
Long-term employee benefits payable | ||
Provisions | ||
Deferred income | 1,059,337,251.92 | 1,063,699,676.16 |
Deferred tax liabilities | 192,205,910.18 | 135,751,304.31 |
Other non-current liabilities | ||
Total non-current liabilities | 7,004,531,790.83 | 6,351,199,635.11 |
Total liabilities | 15,186,785,915.28 | 12,828,456,614.53 |
Equity: | ||
Share capital | 3,090,907,356.00 | 2,578,394,760.00 |
Other equity instruments | ||
Including: Preferred shares | ||
Perpetual bonds | ||
Capital reserve | 3,613,594,210.48 | 4,121,063,080.96 |
Less: Treasury shares | 500,059,711.25 | 320,360,784.48 |
Items | September 30, 2022 | January 1, 2022 |
Other comprehensive income | 92,264,221.51 | -1,614,172.31 |
Special reserve | 26,682,819.24 | 12,692,218.51 |
Surplus reserve | 1,289,197,380.00 | 1,289,197,380.00 |
General risk reserve | ||
Undistributed profit | 15,369,717,277.62 | 14,152,465,528.17 |
Total equity attributable to the parent company | 22,982,303,553.60 | 21,831,838,010.85 |
Non-controlling interest | 76,819,431.45 | 63,730,851.41 |
Total equity | 23,059,122,985.05 | 21,895,568,862.26 |
Total liabilities & equity | 38,245,908,900.33 | 34,724,025,476.79 |
Legal representative: Hu Baifan Officer in charge of accounting: Shi Guanqun Head of accounting department: Wang Xiaobi
2. Consolidated income statement for Q1-Q3
Unit: RMB Yuan
Items | Q1~Q3 2022 | Q1~Q3 2021 |
I. Total operating revenue | 11,910,018,133.43 | 10,614,042,692.54 |
Including: Operating revenue | 11,910,018,133.43 | 10,614,042,692.54 |
Interest income | ||
Premiums earned | ||
Revenue from handling charges and commission | ||
II. Total operating cost | 8,534,027,513.81 | 6,840,700,429.91 |
Including: Operating cost | 7,397,206,010.54 | 5,665,348,246.11 |
Interest expenses | ||
Handling charges and commission expenditures | ||
Surrender value | ||
Net payment of insurance claims | ||
Net provision of insurance policy reserve | ||
Premium bonus expenditures | ||
Reinsurance expenses | ||
Taxes and surcharges | 80,266,088.04 | 88,269,874.64 |
Selling expenses | 88,982,628.60 | 88,864,094.38 |
Administrative expenses | 344,402,783.49 | 291,525,770.12 |
R&D expenses | 600,093,376.48 | 520,062,056.43 |
Financial expenses | 23,076,626.66 | 186,630,388.23 |
Including: Interest expenses | 236,654,223.33 | 246,262,466.47 |
Items | Q1~Q3 2022 | Q1~Q3 2021 |
Interest income | 109,571,188.41 | 116,114,608.98 |
Add: Other income | 130,273,543.85 | 100,525,022.26 |
Investment income (or less: losses) | 79,284,084.27 | 59,117,130.85 |
Including: Investment income from associates and joint ventures | 61,815,175.50 | 28,674,263.48 |
Gains from derecognition of financial assets at amortized cost | ||
Gains on foreign exchange (or less: losses) | ||
Gains on net exposure to hedging risk (or less: losses) | ||
Gains on changes in fair value (or less: losses) | -53,501,499.68 | 33,837,177.78 |
Credit impairment loss (or less: losses) | 30,020,718.39 | -24,034,277.06 |
Assets impairment loss (or less: losses) | -12,151,215.72 | -10,877,539.41 |
Gains on asset disposal (or less: losses) | 1,227,407.46 | 282,056.79 |
III. Operating profit (or less: losses) | 3,551,143,658.19 | 3,932,191,833.84 |
Add: Non-operating revenue | 4,711,191.13 | 11,062,337.09 |
Less: Non-operating expenditures | 2,750,908.34 | 3,786,996.91 |
IV. Profit before tax (or less: total loss) | 3,553,103,940.98 | 3,939,467,174.02 |
Less: Income tax | 529,208,314.51 | 533,069,053.25 |
V. Net profit (or less: net loss) | 3,023,895,626.47 | 3,406,398,120.77 |
(I) Categorized by the continuity of operations | ||
1. Net profit from continuing operations (or less: net loss) | 3,023,895,626.47 | 3,406,398,120.77 |
2. Net profit from discontinued operations (or less: net loss) | ||
(II) Categorized by the portion of equity ownership | ||
1. Net profit attributable to owners of parent company | 3,011,045,838.25 | 3,391,995,645.90 |
2.Net profit attributable to non-controlling shareholders | 12,849,788.22 | 14,402,474.87 |
VI. Other comprehensive income after tax | 94,117,185.64 | -14,782,885.55 |
Items attributable to the owners of the parent company | 93,878,393.82 | -10,157,427.46 |
(I) Not to be reclassified subsequently to profit or loss | ||
1. Changes in remeasurement on the net defined benefit plan | ||
2. Items under equity method that will not be reclassified to profit or loss | ||
3. Changes in fair value of other equity instrument investments | ||
4. Changes in fair value of own credit risk | ||
5. Others |
Items | Q1~Q3 2022 | Q1~Q3 2021 |
(II) To be reclassified subsequently to profit or loss | 93,878,393.82 | -10,157,427.46 |
1. Items under equity method that may be reclassified to profit or loss | ||
2. Changes in fair value of other debt investments | ||
3. Profit or loss from reclassification of financial assets into other comprehensive income | ||
4. Provision for credit impairment of other debt investments | ||
5. Cash flow hedging reserve | ||
6. Translation reserve | 93,878,393.82 | -10,157,427.46 |
7. Others | ||
Items attributable to non-controlling shareholders | 238,791.82 | -4,625,458.09 |
VII. Total comprehensive income | 3,118,012,812.11 | 3,391,615,235.22 |
(I)Items attributable to the owners of the parent company | 3,104,924,232.07 | 3,381,838,218.44 |
(II) Items attributable to non-controlling shareholders | 13,088,580.04 | 9,777,016.78 |
VIII. Earnings per share (EPS): | ||
(I) Basic EPS (yuan per share) | 0.98 | 1.10 |
(II) Diluted EPS (yuan per share) | 0.98 | 1.10 |
Net profit realized by the combined party in business combination under common control before the business combination in the currentperiod was 0.00 yuan, and net profit realized by the combined party in the previous period was 0.00 yuan.Legal representative: Hu Baifan Officer in charge of accounting: Shi Guanqun Head of accounting department: Wang Xiaobi
3.Consolidated Cash Flow Statement for Q1~Q3
Unit: RMB Yuan
Items | Q1~Q3 2022 | Q1~Q3 2021 |
I. Cash flows from operating activities: | ||
Cash receipts from sale of goods or rendering of services | 12,071,389,906.85 | 10,444,510,249.93 |
Net increase of client deposit and interbank deposit | ||
Net increase of central bank loans | ||
Net increase of loans from other financial institutions | ||
Cash receipts from original insurance contract premium | ||
Net cash receipts from reinsurance | ||
Net increase of policy-holder deposit and investment | ||
Cash receipts from interest, handling charges and commission | ||
Net increase of loans from others |
Items | Q1~Q3 2022 | Q1~Q3 2021 |
Net increase of repurchase | ||
Net cash receipts from agency security transaction | ||
Receipts of tax refund | 850,452,324.18 | 663,717,474.82 |
Other cash receipts related to operating activities | 287,124,257.37 | 262,072,642.42 |
Subtotal of cash inflows from operating activities | 13,208,966,488.40 | 11,370,300,367.17 |
Cash payments for goods purchased and services received | 8,139,683,463.77 | 5,626,420,552.09 |
Net increase of loans and advances to clients | ||
Net increase of central bank deposit and interbank deposit | ||
Cash payments for insurance indemnities of original insurance contracts | ||
Net increase of loans to others | ||
Cash payments for interest, handling charges and commission | ||
Cash payments for policy bonus | ||
Cash paid to and on behalf of employees | 1,437,531,327.11 | 1,119,035,556.90 |
Cash payments for taxes and rates | 831,112,937.34 | 683,137,156.56 |
Other cash payments related to operating activities | 273,152,396.11 | 84,977,263.27 |
Subtotal of cash outflows from operating activities | 10,681,480,124.33 | 7,513,570,528.82 |
Net cash flows from operating activities | 2,527,486,364.07 | 3,856,729,838.35 |
II. Cash flows from investing activities: | ||
Cash receipts from withdrawal of investments | ||
Cash receipts from investment income | 40,762,530.88 | 41,295,727.22 |
Net cash receipts from the disposal of fixed assets, intangible assets and other long-term assets | 6,903,703.28 | 12,356,503.13 |
Net cash receipts from the disposal of subsidiaries & other business units | ||
Other cash receipts related to investing activities | 1,827,620,203.77 | 1,800,000,000.00 |
Subtotal of cash inflows from investing activities | 1,875,286,437.93 | 1,853,652,230.35 |
Cash payments for the acquisition of fixed assets, intangible assets and other long-term assets | 2,895,146,588.78 | 2,191,412,359.35 |
Cash payments for investments | ||
Net increase of pledged borrowings | ||
Net cash payments for the acquisition of subsidiaries & other business units | 5,589,983.30 | 83,904,479.79 |
Other cash payments related to investing activities | 616,205,784.81 | 1,600,000,000.00 |
Subtotal of cash outflows from investing activities | 3,516,942,356.89 | 3,875,316,839.14 |
Net cash flows from investing activities | -1,641,655,918.96 | -2,021,664,608.79 |
Items | Q1~Q3 2022 | Q1~Q3 2021 |
III. Cash flows from financing activities: | ||
Cash receipts from absorbing investments | ||
Including: Cash received by subsidiaries from non-controlling shareholders as investments | ||
Cash receipts from borrowings | 4,749,513,521.52 | 4,848,268,656.73 |
Other cash receipts related to financing activities | ||
Subtotal of cash inflows from financing activities | 4,749,513,521.52 | 4,848,268,656.73 |
Cash payments for the repayment of borrowings | 2,350,075,021.90 | 3,411,549,400.71 |
Cash payments for distribution of dividends or profits and for interest expenses | 2,051,162,620.80 | 1,771,907,984.48 |
Including: Cash paid by subsidiaries to non-controlling shareholders as dividend or profit | ||
Other cash payments related to financing activities | 4,421,020.29 | 7,086,761.24 |
Subtotal of cash outflows from financing activities | 4,405,658,662.99 | 5,190,544,146.43 |
Net cash flows from financing activities | 343,854,858.53 | -342,275,489.70 |
IV. Effect of foreign exchange rate changes on cash & cash equivalents | -13,554,069.00 | -41,320,150.82 |
V. Net increase in cash and cash equivalents | 1,216,131,234.64 | 1,451,469,589.04 |
Add: Opening balance of cash and cash equivalents | 5,714,537,538.23 | 4,669,306,776.09 |
VI. Closing balance of cash and cash equivalents | 6,930,668,772.87 | 6,120,776,365.13 |
II Independent Auditor’s ReportWhether the financial statements above have been audited by an independent auditor.
□Yes √ No
These financial statements have not been audited by such an auditor.
Board of Directors of Zhejiang NHU Company Ltd
October 26,2022